Citations (78)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
José Angelo Lauletta Lindoso, Mirella Alves Cunha, Igor Thiago Queiroz & Carlos Henrique Valente Moreira. (2016) Leishmaniasis–HIV coinfection: current challenges. HIV/AIDS - Research and Palliative Care 8, pages 147-156.
Read now
Read now
Richard Reithinger. (2008) Diagnosis and treatment of cutaneous leishmaniasis. Expert Review of Dermatology 3:3, pages 315-327.
Read now
Read now
Margriet den Boer & Robert N Davidson. (2006) Treatment options for visceral leishmaniasis. Expert Review of Anti-infective Therapy 4:2, pages 187-197.
Read now
Read now
K. Pandey, P. K. Sinha, V. N. R. Das, N. Kumar, S. M. Hassan, N. Verma, C. S. Lal, S. Bimal, P. Das & S. K. Bhattacharya. (2005) HIV-1 infection, visceral leishmaniasis, Koch's chest and tuberculous meningitis in the same patient — a case report. Annals of Tropical Medicine & Parasitology 99:8, pages 807-811.
Read now
Read now
Articles from other publishers (74)
Hend Alotaibi, Abdulelah Aldossari & Sultan Alnasser. (2023) Impetiginous Cutaneous Leishmaniasis after COVID-19 Infection in a Patient with Poor Cardiac Profile: A Case Report and Literature Review. Tropical Medicine and Infectious Disease 8:9, pages 443.
Crossref
Crossref
Mohammed Ahmed Elawad, Modawy Elnour Modawy Elkhalifa, Alashary Adam Eisa Hamdoon, Liga Hasan Mohammed Salim, Zeeshan Ahmad & Muhammad Ayaz. (2023) Natural products derived steroids as potential anti-leishmanial agents; disease prevalence, underlying mechanisms and future perspectives. Steroids 193, pages 109196.
Crossref
Crossref
Debnarayan Khatua, Debashree Guha, Anupam De & Budhaditya Mukherjee. 2023. Pathobiology of Parasitic Protozoa: Dynamics and Dimensions. Pathobiology of Parasitic Protozoa: Dynamics and Dimensions
175
187
.
Ana Victoria Ibarra-Meneses, Audrey Corbeil, Victoria Wagner, Chukwuemeka Onwuchekwa & Christopher Fernandez-Prada. (2022) Identification of asymptomatic Leishmania infections: a scoping review. Parasites & Vectors 15:1.
Crossref
Crossref
Jalal Alshaweesh, Risa Nakamura, Yuka Tanaka, Mizuki Hayashishita, Abu Musa, Mihoko Kikuchi, Daniel Ken Inaoka & Shinjiro Hamano. (2022) Leishmania major Strain-Dependent Macrophage Activation Contributes to Pathogenicity in the Absence of Lymphocytes. Microbiology Spectrum 10:5.
Crossref
Crossref
Isha Saini, Jyoti Joshi & Sukhbir Kaur. (2022) Unwelcome prevalence of leishmaniasis with several other infectious diseases. International Immunopharmacology 110, pages 109059.
Crossref
Crossref
Pingping Song, Shuai Chen, Xiaoyu Tan, Yanjun Gao, Juanjuan Fu, Zhiqing You, Chengtan Wang, Qigang Zhao & Feng Pang. (2021) Metagenomic Analysis Identifying a Rare Leishmania Infection in an Adult With AIDS. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Crossref
Jorge Alvar, Margriet den Boer & Daniel Argaw Dagne. (2021) Towards the elimination of visceral leishmaniasis as a public health problem in east Africa: reflections on an enhanced control strategy and a call for action. The Lancet Global Health 9:12, pages e1763-e1769.
Crossref
Crossref
Devipriya J. S.Ashok Kumar Gupta, Rajendra Babu Veeri, Pavan Garapati, Rishikesh Kumar, Sameer Dhingra, Krishna Murti, V. Ravichandiran & Krishna Pandey. (2021) Knowledge, attitude and practices towards visceral leishmaniasis among HIV patients: A cross-sectional study from Bihar, India. PLOS ONE 16:8, pages e0256239.
Crossref
Crossref
Rahat Zarin, Amir Khan, Mustafa Inc, Usa Wannasingha Humphries & Touria Karite. (2021) Dynamics of five grade leishmania epidemic model using fractional operator with Mittag–Leffler kernel. Chaos, Solitons & Fractals 147, pages 110985.
Crossref
Crossref
Kristien Cloots, Pia Marino, Sakib Burza, Naresh Gill, Marleen Boelaert & Epco Hasker. (2021) Visceral Leishmaniasis-HIV Coinfection as a Predictor of Increased Leishmania Transmission at the Village Level in Bihar, India. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Crossref
M. Zamir, F. Nadeem & G. Zaman. (2020) Optimal control of visceral, cutaneous and post kala-azar leishmaniasis. Advances in Difference Equations 2020:1.
Crossref
Crossref
Andrea Piccioni, Federico Valletta, Christian Zanza, Yaroslava Longhitano, Enrico Torelli, Tommaso de Cunzo, Alessandra Esperide, Mattia Brigida, Veronica Ojetti, Marcello Covino, Samanta Taurone, Massimo Ralli, Marco Artico & Francesco Franceschi. (2020) Rapid Clinical Management of Leishmaniasis in Emergency Department: A Case Report with Clinical Review of Recent Literature. Biology 9:11, pages 351.
Crossref
Crossref
Sakarn CharoensakulchaiLertwut BualertJipada Manomat, Mathirut MungthinSaovanee LeelayoovaPeerapan Tan-ariya, Suradej Siripattanapipong, Tawee NaaglorPhunlerd Piyaraj. (2020) Risk Factors of Leishmania Infection among HIV-Infected Patients in Trang Province, Southern Thailand: A Study on Three Prevalent Species. The American Journal of Tropical Medicine and Hygiene 103:4, pages 1502-1509.
Crossref
Crossref
Kahime Kholoud, Lahouari Bounoua, Denis Sereno, MoulayAbdelomain El Hidan & Mohamed Messouli. (2020) Emerging and Re-Emerging Leishmaniases in the Mediterranean Area: What Can Be Learned from a Retrospective Review Analysis of the Situation in Morocco during 1990 to 2010?. Microorganisms 8:10, pages 1511.
Crossref
Crossref
Amir Khan, Rahat Zarin, Mustafa Inc, Gul Zaman & Bandar Almohsen. (2020) Stability analysis of leishmania epidemic model with harmonic mean type incidence rate. The European Physical Journal Plus 135:6.
Crossref
Crossref
Paul M. Kaye, Israel Cruz, Albert Picado, Katrien Van Bocxlaer & Simon L. Croft. (2020) Leishmaniasis immunopathology—impact on design and use of vaccines, diagnostics and drugs. Seminars in Immunopathology 42:3, pages 247-264.
Crossref
Crossref
Nilakshi Samaranayake. 2020. Molecular Advancements in Tropical Diseases Drug Discovery. Molecular Advancements in Tropical Diseases Drug Discovery
21
46
.
Eva H. Clark & Jose A. Serpa. (2019) Tissue Parasites in HIV Infection. Current Infectious Disease Reports 21:12.
Crossref
Crossref
Johan van Griensven, Saskia van Henten, Bewketu Mengesha, Mekibib Kassa, Emebet Adem, Mengistu Endris Seid, Saïd Abdellati, Wondimu Asefa, Tesfa Simegn, Degnachew Debasu, Tadfe Bogale, Yonas Gedamu, Dorien Van Den Bossche, Wim Adriaensen, Gert Van der Auwera, Lieselotte Cnops, Florian Vogt & Ermias Diro. (2019) Longitudinal evaluation of asymptomatic Leishmania infection in HIV-infected individuals in North-West Ethiopia: A pilot study. PLOS Neglected Tropical Diseases 13:10, pages e0007765.
Crossref
Crossref
Eva Clark & Jose A. Serpa. (2019) Tropical Diseases in HIV. Current Treatment Options in Infectious Diseases 11:3, pages 215-232.
Crossref
Crossref
Sophia Malli, Sebastien Pomel, Indira Dennemont, Philippe M. Loiseau & Kawthar Bouchemal. (2019) Combination of amphotericin B and chitosan platelets for the treatment of experimental cutaneous leishmaniasis: Histological and immunohistochemical examinations. Journal of Drug Delivery Science and Technology 50, pages 34-41.
Crossref
Crossref
Diego Lins GuedesZulma MedeirosElis Dionísio da SilvaAudrey Violeta Martins de VasconcelosMariana Santana da SilvaMaria Almerice Lopes da SilvaPaulo Sérgio Ramos de AraújoDemócrito de Barros Miranda-Filho. (2018) Visceral Leishmaniasis in Hospitalized HIV-Infected Patients in Pernambuco, Brazil. The American Journal of Tropical Medicine and Hygiene 99:6, pages 1541-1546.
Crossref
Crossref
Epke A Le Rutte, Lloyd A C Chapman, Luc E Coffeng, José A Ruiz-Postigo, Piero L Olliaro, Emily R Adams, Epco C Hasker, Marleen C Boelaert, T Deirdre Hollingsworth, Graham F Medley & Sake J de Vlas. (2018) Policy Recommendations From Transmission Modeling for the Elimination of Visceral Leishmaniasis in the Indian Subcontinent. Clinical Infectious Diseases 66:suppl_4, pages S301-S308.
Crossref
Crossref
SILVIA R. B. ULIANA, CRISTIANA T. TRINCONI & ADRIANO C. COELHO. (2017) Chemotherapy of leishmaniasis: present challenges. Parasitology 145:4, pages 464-480.
Crossref
Crossref
Shyam Sundar & Jaya Chakravarty. 2018. Drug Resistance in Leishmania Parasites. Drug Resistance in Leishmania Parasites
159
176
.
Emily E. Evans & Mark J. Siedner. (2017) Tropical Parasitic Infections in Individuals Infected With HIV. Current Tropical Medicine Reports 4:4, pages 268-280.
Crossref
Crossref
Abdullah M. Al-Majid, Muhammad Iqbal Choudhary, Sammer Yousuf, Almas Jabeen, Rehan Imad, Kulsoom Javeed, Nimra Naveed Shaikh, Alba Collado, Eleni Sioriki, Fady Nahra & Steven P. Nolan. (2017) In vitro Biological Activities of Gold(I) and Gold(III) Bis(N-Heterocyclic Carbene) Complexes. ChemistrySelect 2:19, pages 5316-5320.
Crossref
Crossref
Shyam Sundar & Jaya Chakravarty. 2017. Antimicrobial Drug Resistance. Antimicrobial Drug Resistance
1293
1304
.
Muhammad Zamir, Gul Zaman & Ali Saleh Alshomrani. (2016) Sensitivity Analysis and Optimal Control of Anthroponotic Cutaneous Leishmania. PLOS ONE 11:8, pages e0160513.
Crossref
Crossref
Eduard E Zijlstra. (2016) Visceral leishmaniasis: a forgotten epidemic. Archives of Disease in Childhood 101:6, pages 561-567.
Crossref
Crossref
Christelle Pomares, Pierre Marty, Anne Laure Bañuls, Emmanuel Lemichez, Francine Pratlong, Benoît Faucher, Fakhri Jeddi, Sandy Moore, Grégory Michel, Srikanth Aluru, Renaud Piarroux & Mallorie Hide. (2016) Genetic Diversity and Population Structure of Leishmania infantum from Southeastern France: Evaluation Using Multi-Locus Microsatellite Typing. PLOS Neglected Tropical Diseases 10:1, pages e0004303.
Crossref
Crossref
N. Hussaini, J. M-S Lubuma, K. Barley & A.B. Gumel. (2016) Mathematical analysis of a model for AVL–HIV co-endemicity. Mathematical Biosciences 271, pages 80-95.
Crossref
Crossref
K.S. Rock, R.J. Quinnell, G.F. Medley & O. Courtenay. 2016. Mathematical Models for Neglected Tropical Diseases - Essential Tools for Control and Elimination, Part B. Mathematical Models for Neglected Tropical Diseases - Essential Tools for Control and Elimination, Part B
49
131
.
Asrat Hailu, Daniel Argaw Dagne & Marleen Boelaert. 2016. Neglected Tropical Diseases - Sub-Saharan Africa. Neglected Tropical Diseases - Sub-Saharan Africa
87
112
.
Abdullah M. Al-Majid, Sammer Yousuf, M. Iqbal Choudhary , Fady Nahra & Steven P. Nolan . (2016) Gold-NHC complexes as potent bioactive compounds. ChemistrySelect 1:1, pages 76-80.
Crossref
Crossref
Ermias Diro, Koert Ritmeijer, Marleen Boelaert, Fabiana Alves, Rezika Mohammed, Charles Abongomera, Raffaella Ravinetto, Maaike De Crop, Helina Fikre, Cherinet Adera, Robert Colebunders, Harry van Loen, Joris Menten, Lutgarde Lynen, Asrat Hailu & Johan van Griensven. (2015) Use of Pentamidine As Secondary Prophylaxis to Prevent Visceral Leishmaniasis Relapse in HIV Infected Patients, the First Twelve Months of a Prospective Cohort Study. PLOS Neglected Tropical Diseases 9:10, pages e0004087.
Crossref
Crossref
J. van Griensven. (2014) Editorial Commentary: Visceral Leishmaniasis and HIV Coinfection in Bihar, India: A Wake-up Call?. Clinical Infectious Diseases 59:4, pages 556-558.
Crossref
Crossref
Guilherme Almeida Rosa da Silva, Daniel Sugui, Rafael Fernandes Nunes, Karime de Azevedo, Marcelo de Azevedo, Alexandre Marques, Carlos Martins & Fernando Raphael de Almeida Ferry. (2014) Mucocutaneous Leishmaniasis/HIV Coinfection Presented as a Diffuse Desquamative Rash. Case Reports in Infectious Diseases 2014, pages 1-5.
Crossref
Crossref
Christine A. Petersen & Kevin J. Esch. 2014. Pathogenesis of Leishmaniasis. Pathogenesis of Leishmaniasis
67
75
.
Surendra Uranw, Epco Hasker, Lalita Roy, Filip Meheus, Murari Lal Das, Narayan Raj Bhattarai, Suman Rijal & Marleen Boelaert. (2013) An outbreak investigation of visceral leishmaniasis among residents of Dharan town, eastern Nepal, evidence for urban transmission of Leishmania donovani. BMC Infectious Diseases 13:1.
Crossref
Crossref
Gabriele Sorci, Stéphane Cornet & Bruno Faivre. (2013) Immunity and the emergence of virulent pathogens. Infection, Genetics and Evolution 16, pages 441-446.
Crossref
Crossref
Ifeoma Okwor & Jude Eze Uzonna. (2013) The immunology of Leishmania/HIV co-infection. Immunologic Research 56:1, pages 163-171.
Crossref
Crossref
Joseph N. Jarvis & Diana N. Lockwood. (2013) Clinical aspects of visceral leishmaniasis in HIV infection. Current Opinion in Infectious Diseases 26:1, pages 1-9.
Crossref
Crossref
Shyam Sundar & Jaya Chakravarty. 2013. Drug Resistance in Leishmania Parasites. Drug Resistance in Leishmania Parasites
183
198
.
Shyam Sundar & Jaya Chakravarty. 2013. Challenges in Infectious Diseases. Challenges in Infectious Diseases
247
264
.
Omer Bébé Ngouateu, Pierre Kollo, Christophe Ravel, Jacques Dereure, Pierre Kamtchouing, Albert Same-Ekobo, Esther von Stebut, Marcus Maurer & Blaise Dondji. (2012) Clinical features and epidemiology of cutaneous leishmaniasis and Leishmania major/HIV co-infection in Cameroon: results of a large cross-sectional study. Transactions of the Royal Society of Tropical Medicine and Hygiene 106:3, pages 137-142.
Crossref
Crossref
Nicola Bulled & Merrill Singer. (2009) Syringe-Mediated Syndemics. AIDS and Behavior 15:7, pages 1539-1545.
Crossref
Crossref
Yingwei Wang, Yang Chen, Lijun Xin, Stephen M. Beverley, Eric D. Carlsen, Vsevolod Popov, Kwang-Poo Chang, Ming Wang & Lynn Soong. (2011)
Differential Microbicidal Effects of Human Histone Proteins H2A and H2B on
Leishmania
Promastigotes and Amastigotes
. Infection and Immunity 79:3, pages 1124-1133.
Crossref
Crossref
R. Inocencio da Luz, G. A. S. Romero, M. E. Dorval, I. Cruz, C. Canavate, J.-C. Dujardin, T. Van Assche, P. Cos & L. Maes. (2011) Drug susceptibility of Leishmania infantum (syn. Leishmania chagasi) isolates from Brazilian HIV-positive and HIV-negative patients. Journal of Antimicrobial Chemotherapy 66:3, pages 677-679.
Crossref
Crossref
Pranav Kumar, Robert Lodge, Nathalie Trudel, Michel Ouellet, Marc Ouellette & Michel J. Tremblay. (2010) Nelfinavir, an HIV-1 Protease Inhibitor, Induces Oxidative Stress–Mediated, Caspase-Independent Apoptosis in Leishmania Amastigotes. PLoS Neglected Tropical Diseases 4:3, pages e642.
Crossref
Crossref
Johan van Griensven, Manica Balasegaram, Filip Meheus, Jorge Alvar, Lutgarde Lynen & Marleen Boelaert. (2010) Combination therapy for visceral leishmaniasis. The Lancet Infectious Diseases 10:3, pages 184-194.
Crossref
Crossref
Anuj Mubayi, Carlos Castillo-Chavez, Gerardo Chowell, Christopher Kribs-Zaleta, Niyamat Ali Siddiqui, Narendra Kumar & Pradeep Das. (2010) Transmission dynamics and underreporting of Kala-azar in the Indian state of Bihar. Journal of Theoretical Biology 262:1, pages 177-185.
Crossref
Crossref
Kotb Abass, Hekma Saad & Alaa A Abd-Elsayed. (2009) The first case of isolated facial cutanenous leishmaniasis in a Down syndrome infant: a case report and review of the literature. Cases Journal 2:1.
Crossref
Crossref
R. J. QUINNELL & O. COURTENAY. (2009) Transmission, reservoir hosts and control of zoonotic visceral leishmaniasis. Parasitology 136:14, pages 1915-1934.
Crossref
Crossref
Russell E. Coleman, Lisa P. Hochberg, Katherine I. Swanson, John S. Lee, James C. Mcavin, John K. Moulton, David O. Eddington, Jennifer L. Groebner, Monica L. O’guinn & John L. Putnam. (2009)
Impact of Phlebotomine Sand Flies on U.S. Military Operations at Tallil Air Base, Iraq: 4. Detection and Identification of
Leishmania
Parasites in Sand Flies
. Journal of Medical Entomology 46:3, pages 649-663.
Crossref
Crossref
Sami Ben Hadj Ahmed, Leila Touihri, Yessine Chtourou, Koussay Dellagi & Chokri Bahloul. (2009) DNA based vaccination with a cocktail of plasmids encoding immunodominant Leishmania (Leishmania) major antigens confers full protection in BALB/c mice. Vaccine 27:1, pages 99-106.
Crossref
Crossref
Shyam Sundar & Madhukar Rai. 2009. Antimicrobial Drug Resistance. Antimicrobial Drug Resistance
1101
1112
.
Katrin Kuhls, Carmen Chicharro, Carmen Cañavate, Sofia Cortes, Lenea Campino, Christos Haralambous, Ketty Soteriadou, Francine Pratlong, Jean-Pierre Dedet, Isabel Mauricio, Michael Miles, Matthias Schaar, Sebastian Ochsenreither, Oliver A. Radtke & Gabriele Schönian. (2008) Differentiation and Gene Flow among European Populations of Leishmania infantum MON-1. PLoS Neglected Tropical Diseases 2:7, pages e261.
Crossref
Crossref
Ravendra Garg, Robert Lodge, Albert Descoteaux & Michel J. Tremblay. (2008)
Leishmania infantum
Promastigotes Reduce Entry of HIV‐1 into Macrophages through a Lipophosphoglycan‐Mediated Disruption of Lipid Rafts
. The Journal of Infectious Diseases 197:12, pages 1701-1708.
Crossref
Crossref
JAMES O. LLOYD-SMITH, MARY POSS & BRYAN T. GRENFELL. (2008) HIV-1/parasite co-infection and the emergence of new parasite strains. Parasitology 135:7, pages 795-806.
Crossref
Crossref
Dilvani O. Santos, Carlos E. R. Coutinho, Maria F. Madeira, Carolina G. Bottino, Rodrigo T. Vieira, Samara B. Nascimento, Alice Bernardino, Saulo C. Bourguignon, Suzana Corte-Real, Rosa T. Pinho, Carlos Rangel Rodrigues & Helena C. Castro. (2008) Leishmaniasis treatment—a challenge that remains: a review. Parasitology Research 103:1, pages 1-10.
Crossref
Crossref
Richard Reithinger, Jean-Claude Dujardin, Hechmi Louzir, Claude Pirmez, Bruce Alexander & Simon Brooker. (2007) Cutaneous leishmaniasis. The Lancet Infectious Diseases 7:9, pages 581-596.
Crossref
Crossref
Jeffrey Shaw. (2007) [NO TITLE AVAILABLE]. Memórias do Instituto Oswaldo Cruz 102:5, pages 541-547.
Crossref
Crossref
Anne-Laure Bañuls, Mallorie Hide & Franck Prugnolle. 2007. Advances in Parasitology Volume 64. Advances in Parasitology Volume 64
1
458
.
Christophe Ravel, Sofia Cortes, Francine Pratlong, Florent Morio, Jean-Pierre Dedet & Lenea Campino. (2006) First report of genetic hybrids between two very divergent Leishmania species: Leishmania infantum and Leishmania major. International Journal for Parasitology 36:13, pages 1383-1388.
Crossref
Crossref
Filipe Dantas-Torres & Sinval Pinto Brandão-Filho. (2006) Visceral leishmaniasis in Brazil: revisiting paradigms of epidemiology and control. Revista do Instituto de Medicina Tropical de São Paulo 48:3, pages 151-156.
Crossref
Crossref
Filipe Dantas-Torres. (2006) Do any insects other than phlebotomine sandflies (Diptera: Psychodidae) transmit Leishmania infantum (Kinetoplastida: Trypanosomatidae) from dog to dog?. Veterinary Parasitology 136:3-4, pages 379-380.
Crossref
Crossref
Simon L. Croft, Shyam Sundar & Alan H. Fairlamb. (2006) Drug Resistance in Leishmaniasis. Clinical Microbiology Reviews 19:1, pages 111-126.
Crossref
Crossref
Brice Rotureau. (2006) Are New World leishmaniases becoming anthroponoses?. Medical Hypotheses 67:5, pages 1235-1241.
Crossref
Crossref
S. Harrus & G. Baneth. (2005) Drivers for the emergence and re-emergence of vector-borne protozoal and bacterial diseases. International Journal for Parasitology 35:11-12, pages 1309-1318.
Crossref
Crossref
Jaime A. Valderrama, Carlos Zamorano, M. Florencia González, Eric Prina & Alain Fournet. (2005) Studies on quinones. Part 39: Synthesis and leishmanicidal activity of acylchloroquinones and hydroquinones. Bioorganic & Medicinal Chemistry 13:13, pages 4153-4159.
Crossref
Crossref
C. Schraner, B. Hasse, U. Hasse, D. Baumann, A. Faeh, G. Burg, F. Grimm, A. Mathis, R. Weber & H. F. Gunthard. (2005) Successful Treatment with Miltefosine of Disseminated Cutaneous Leishmaniasis in a Severely Immunocompromised Patient Infected with HIV-1. Clinical Infectious Diseases 40:12, pages e120-e124.
Crossref
Crossref
Luis Rivas, Javier Moreno, Carmen Cañavate & Jorge Alvar. (2004) Virulence and disease in leishmaniasis: what is relevant for the patient?. Trends in Parasitology 20:7, pages 297-301.
Crossref
Crossref